Micromedic announced successful results of a clinical study designed to detect prostate cancer

Micromedic announced successful results of a clinical study designed to detect prostate cancer

 

Micromedic Technologies, announced successful results of a clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect® technology. The study successfully detected cells originated from the prostate in urine samples. Micromedic's product is designed to allow for the first time, by a simple and non-invasive method, for direct and accurate detection of malignant prostate cells in urine samples.

Link to complete article 

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi